“Sofosbuvir Plus Daclatasvir Without Ribavirin for the Treatment of Chronic Hepatitis C in Patients With Decompensated Liver Disease: Response of Sofosbuvir Plus Daclatasvir in Decompensated Cirrhosis”. Journal of Fatima Jinnah Medical University, vol. 14, no. 1, July 2020, pp. 41-44, https://doi.org/10.37018/WOXS1774.